RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Metabolic and Endocrinology Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
Kwang Dong Pharmaceutical Co., Ltd. (009290) - Financial and Strategic SWOT Analysis Review
May 2011 - 25 pages - $125
Company Financials: Neurocrine Biosciences, Inc.
Jan 2010 - $75
Ildong Pharmaceutical Co., Ltd. (000230) - Financial and Strategic SWOT Analysis Review
May 2011 - 25 pages - $125
KV Pharmaceutical Company: SWOT Analysis & Company Profile
Nov 2010 - 27 pages - $99
Neuro Endocrine Carcinoma - Pipeline Review, Q2 2011
Apr 2011 - 100 pages - $500
Takeda Pharmaceutical Company Limited: SWOT Analysis & Company Profile
Apr 2010 - 17 pages - $99
Dong-A Pharmaceutical Co., Ltd.: SWOT Analysis & Company Profile
Nov 2010 - 23 pages - $99
Daewoong Pharmaceutical Co., Ltd.: SWOT Analysis & Company Profile
Nov 2010 - 24 pages - $99
Ono Pharmaceutical Co., Ltd.: SWOT Analysis & Company Profile
Sep 2010 - 24 pages - $99
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Therapeutic target
Endocrinology del
Endocrine system del

Browse By

Industry sector
Generics
Nutrition
OTC/Non-Prescription
Pediatric
Personal Care
Prescription
Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us